Concepts (110)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Intracranial Arteriovenous Malformations | 20 | 2021 | 48 | 3.120 |
Why?
|
| Radiosurgery | 21 | 2021 | 56 | 2.900 |
Why?
|
| Embolization, Therapeutic | 8 | 2021 | 23 | 1.030 |
Why?
|
| Central Nervous System Vascular Malformations | 3 | 2020 | 10 | 0.770 |
Why?
|
| Arteriovenous Fistula | 5 | 2019 | 12 | 0.770 |
Why?
|
| Stents | 4 | 2012 | 66 | 0.600 |
Why?
|
| Intracranial Aneurysm | 6 | 2019 | 10 | 0.500 |
Why?
|
| Retrospective Studies | 20 | 2021 | 2485 | 0.500 |
Why?
|
| Treatment Outcome | 19 | 2021 | 1586 | 0.470 |
Why?
|
| Neurosurgical Procedures | 2 | 2015 | 27 | 0.460 |
Why?
|
| Angiography, Digital Subtraction | 1 | 2014 | 9 | 0.450 |
Why?
|
| Middle Cerebral Artery | 1 | 2014 | 16 | 0.450 |
Why?
|
| Psychomotor Disorders | 1 | 2012 | 9 | 0.390 |
Why?
|
| Infarction, Middle Cerebral Artery | 1 | 2012 | 79 | 0.370 |
Why?
|
| Stroke | 2 | 2014 | 348 | 0.370 |
Why?
|
| Postoperative Hemorrhage | 5 | 2019 | 15 | 0.360 |
Why?
|
| Carotid Artery, External | 1 | 2011 | 5 | 0.360 |
Why?
|
| Follow-Up Studies | 12 | 2021 | 1051 | 0.350 |
Why?
|
| Postoperative Complications | 8 | 2019 | 253 | 0.310 |
Why?
|
| Adult | 24 | 2021 | 13458 | 0.280 |
Why?
|
| Blood Vessels | 1 | 2008 | 36 | 0.280 |
Why?
|
| Disease Models, Animal | 1 | 2012 | 1554 | 0.260 |
Why?
|
| Male | 25 | 2021 | 22779 | 0.250 |
Why?
|
| Middle Aged | 19 | 2021 | 11819 | 0.240 |
Why?
|
| Female | 26 | 2021 | 24018 | 0.230 |
Why?
|
| Humans | 31 | 2021 | 42163 | 0.230 |
Why?
|
| Hearing Tests | 1 | 2013 | 1 | 0.210 |
Why?
|
| Neonatal Screening | 1 | 2013 | 24 | 0.210 |
Why?
|
| Neck | 1 | 2013 | 20 | 0.210 |
Why?
|
| Cohort Studies | 7 | 2021 | 1729 | 0.190 |
Why?
|
| Adolescent | 12 | 2021 | 5950 | 0.190 |
Why?
|
| Aged | 13 | 2020 | 7982 | 0.180 |
Why?
|
| Polyvinyls | 1 | 2021 | 6 | 0.170 |
Why?
|
| Aged, 80 and over | 8 | 2018 | 2803 | 0.170 |
Why?
|
| Child | 8 | 2019 | 3381 | 0.170 |
Why?
|
| Cavernous Sinus | 1 | 2020 | 3 | 0.170 |
Why?
|
| Cerebral Hemorrhage | 2 | 2019 | 115 | 0.170 |
Why?
|
| Internationality | 5 | 2017 | 38 | 0.160 |
Why?
|
| Basal Ganglia | 1 | 2019 | 20 | 0.150 |
Why?
|
| Thalamus | 1 | 2019 | 34 | 0.150 |
Why?
|
| Seizures | 1 | 2019 | 79 | 0.150 |
Why?
|
| Cerebellum | 1 | 2016 | 78 | 0.130 |
Why?
|
| Risk Factors | 7 | 2019 | 3942 | 0.120 |
Why?
|
| Cranial Nerve Diseases | 1 | 2015 | 1 | 0.120 |
Why?
|
| Cerebral Revascularization | 1 | 2015 | 5 | 0.120 |
Why?
|
| Carotid Arteries | 1 | 2015 | 35 | 0.120 |
Why?
|
| Registries | 3 | 2012 | 431 | 0.120 |
Why?
|
| Basal Ganglia Hemorrhage | 1 | 2014 | 2 | 0.110 |
Why?
|
| Cerebral Angiography | 1 | 2014 | 7 | 0.110 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2014 | 16 | 0.110 |
Why?
|
| Color | 1 | 2014 | 38 | 0.110 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2014 | 90 | 0.100 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2019 | 577 | 0.100 |
Why?
|
| Young Adult | 8 | 2019 | 4936 | 0.100 |
Why?
|
| Puerto Rico | 3 | 2014 | 1376 | 0.100 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2014 | 246 | 0.100 |
Why?
|
| Risk Assessment | 3 | 2012 | 845 | 0.100 |
Why?
|
| Histological Techniques | 1 | 2012 | 12 | 0.100 |
Why?
|
| Diagnostic Techniques, Neurological | 1 | 2012 | 6 | 0.100 |
Why?
|
| Catheterization | 1 | 2012 | 22 | 0.100 |
Why?
|
| Blood Vessel Prosthesis | 1 | 2012 | 5 | 0.100 |
Why?
|
| Microarray Analysis | 1 | 2012 | 64 | 0.100 |
Why?
|
| Infant | 2 | 2013 | 1143 | 0.100 |
Why?
|
| Macaca mulatta | 1 | 2012 | 139 | 0.090 |
Why?
|
| Intracranial Thrombosis | 1 | 2011 | 3 | 0.090 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2012 | 456 | 0.090 |
Why?
|
| Prognosis | 3 | 2020 | 850 | 0.090 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2012 | 246 | 0.090 |
Why?
|
| Blotting, Western | 1 | 2012 | 884 | 0.080 |
Why?
|
| Prostheses and Implants | 1 | 2009 | 18 | 0.080 |
Why?
|
| Reoperation | 1 | 2009 | 31 | 0.080 |
Why?
|
| Prospective Studies | 3 | 2021 | 1574 | 0.080 |
Why?
|
| Child, Preschool | 2 | 2016 | 1516 | 0.070 |
Why?
|
| Radiation Injuries | 2 | 2019 | 23 | 0.070 |
Why?
|
| Gene Expression Profiling | 1 | 2012 | 683 | 0.070 |
Why?
|
| Cytokines | 1 | 2012 | 661 | 0.070 |
Why?
|
| Smoking | 1 | 2014 | 1019 | 0.070 |
Why?
|
| Neurons | 1 | 2012 | 1246 | 0.060 |
Why?
|
| Multivariate Analysis | 2 | 2016 | 638 | 0.060 |
Why?
|
| Severity of Illness Index | 2 | 2017 | 708 | 0.050 |
Why?
|
| Logistic Models | 2 | 2016 | 1001 | 0.050 |
Why?
|
| Sex Factors | 2 | 2016 | 1008 | 0.050 |
Why?
|
| Infant, Newborn | 1 | 2013 | 960 | 0.040 |
Why?
|
| Brain Damage, Chronic | 1 | 2019 | 5 | 0.040 |
Why?
|
| Radiation Dosage | 1 | 2019 | 37 | 0.040 |
Why?
|
| Predictive Value of Tests | 1 | 2019 | 438 | 0.030 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2017 | 10 | 0.030 |
Why?
|
| Radiotherapy Dosage | 1 | 2016 | 8 | 0.030 |
Why?
|
| Mortality | 1 | 2018 | 174 | 0.030 |
Why?
|
| Rupture, Spontaneous | 1 | 2016 | 7 | 0.030 |
Why?
|
| Eligibility Determination | 1 | 2015 | 9 | 0.030 |
Why?
|
| Carotid Artery, Internal | 1 | 2015 | 8 | 0.030 |
Why?
|
| Incidence | 1 | 2019 | 1054 | 0.030 |
Why?
|
| Animals | 1 | 2012 | 16695 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2016 | 512 | 0.030 |
Why?
|
| Age Factors | 1 | 2018 | 1139 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2015 | 358 | 0.030 |
Why?
|
| Cost of Illness | 1 | 2014 | 95 | 0.030 |
Why?
|
| United States | 2 | 2015 | 5072 | 0.020 |
Why?
|
| Constriction, Pathologic | 1 | 2011 | 7 | 0.020 |
Why?
|
| Time Factors | 1 | 2016 | 1848 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2012 | 362 | 0.020 |
Why?
|
| Survival Rate | 1 | 2012 | 353 | 0.020 |
Why?
|
| Comorbidity | 1 | 2012 | 725 | 0.020 |
Why?
|
| Radiography | 1 | 2009 | 72 | 0.020 |
Why?
|
| Secondary Prevention | 1 | 2009 | 47 | 0.020 |
Why?
|
| Cerebral Arteries | 1 | 2009 | 24 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2012 | 1020 | 0.020 |
Why?
|
| Treatment Failure | 1 | 2009 | 61 | 0.020 |
Why?
|
| Prevalence | 1 | 2012 | 1597 | 0.020 |
Why?
|
Rodriguez-Mercado's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(110)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(3)
People in Profiles who have published with this person.
Explore
_
Similar People
(59)
People who share similar concepts with this person.
Explore
_
Same Department
People who are also in this person's primary department.
Explore
_